Cebranopadol: a first in-class example of a nociceptin/orphanin FQ receptor and opioid receptor agonist

被引：41
|
作者：
Lambert, D. G. [1 ]
Bird, M. F. [1 ]
Rowbotham, D. J. [1 ]
机构：
[1] Univ Leicester, Leicester Royal Infirm, Dept Cardiovasc Sci, Div Anaesthesia Crit Care & Pain Management, Leicester LE2 7LX, Leics, England
来源：
BRITISH JOURNAL OF ANAESTHESIA | 2015年 / 114卷 / 03期
关键词：
KNOCK-OUT MICE; MORPHINE-TOLERANCE; DRUG-ABUSE; DEPENDENCE; NOP; PEPTIDE; TARGET;
D O I：
10.1093/bja/aeu332
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：364 / 366
页数：3
相关论文
共 50 条
  • [1] Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist
    Rizzi, Anna
    Cerlesi, Maria Camilla
    Ruzza, Chiara
    Malfacini, Davide
    Ferrari, Federica
    Bianco, Sara
    Costa, Tommaso
    Guerrini, Remo
    Trapella, Claudio
    Calo, Girolamo
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2016, 4 (04):
  • [2] Respiratory Effects of the Nociceptin/Orphanin FQ Peptide and Opioid Receptor Agonist, Cebranopadol, in Healthy Human Volunteers
    Dahan, Albert
    Boom, Merel
    Sarton, Elise
    Hay, Justin
    Groeneveld, Geert Jan
    Neukirchen, Meike
    Bothmer, John
    Aarts, Leon
    Olofsen, Erik
    ANESTHESIOLOGY, 2017, 126 (04) : 697 - 707
  • [3] Cebranopadol: A Novel Potent Analgesic Nociceptin/Orphanin FQ Peptide and Opioid Receptor Agonists
    Linz, Klaus
    Christoph, Thomas
    Tzschentke, Thomas M.
    Koch, Thomas
    Schiene, Klaus
    Gautrois, Michael
    Schroeder, Wolfgang
    Koegel, Babette Y.
    Beier, Horst
    Englberger, Werner
    Schunk, Stefan
    De Vry, Jean
    Jahnel, Ulrich
    Frosch, Stefanie
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 349 (03): : 535 - 548
  • [4] Orphanin FQ nociceptin: an endogenous peptide agonist for the orphan opioid receptor
    Lambert, DG
    Grandy, DK
    BRITISH JOURNAL OF ANAESTHESIA, 1998, 80 (05) : 577 - 578
  • [5] Nociceptin/Orphanin FQ Receptor Activation Attenuates Antinociception Induced by Mixed Nociceptin/Orphanin FQ/μ-Opioid Receptor Agonists
    Khroyan, Taline V.
    Polgar, Willma E.
    Jiang, Faming
    Zaveri, Nurulain T.
    Toll, Lawrence
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 331 (03): : 946 - 953
  • [6] Cebranopadol: a first-in-class potent analgesic agent with agonistic activity at nociceptin/orphanin FQ and opioid receptors
    Salat, Kinga
    Jakubowska, Anna
    Kulig, Katarzyna
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (06) : 837 - 844
  • [7] Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic
    Calo, G.
    Lambert, D. G.
    BRITISH JOURNAL OF ANAESTHESIA, 2018, 121 (05) : 1105 - 1114
  • [8] Opioid-type Respiratory Depressant Side Effects of Cebranopadol in Rats Are Limited by Its Nociceptin/Orphanin FQ Peptide Receptor Agonist Activity
    Linz, Klaus
    Schroeder, Wolfgang
    Frosch, Stefanie
    Christoph, Thomas
    ANESTHESIOLOGY, 2017, 126 (04) : 708 - 715
  • [9] Cebranopadol: A First-in-Class Nociceptin Receptor Agonist for Managing Chronic Pain
    Nair, Abhijit S.
    Mantha, Shyam Prasad
    Pulipaka, Sai Kaushik
    Rayani, Basanth Kumar
    INDIAN JOURNAL OF PALLIATIVE CARE, 2020, 26 (01) : 147 - 148
  • [10] Nociceptin/orphanin FQ receptor ligands
    Calo, G
    Bigoni, R
    Rizzi, A
    Guerrini, R
    Salvadori, S
    Regoli, D
    PEPTIDES, 2000, 21 (07) : 935 - 947
12345